Annual EBIT
-$108.92 M
+$9.21 M+7.80%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual earnings before interest & taxes is -$108.92 million, with the most recent change of +$9.21 million (+7.80%) on December 31, 2022.
- During the last 3 years, EVLO annual EBIT has fallen by -$22.57 million (-26.13%).
- EVLO annual EBIT is now -736.28% below its all-time high of -$13.03 million, reached on December 31, 2016.
Performance
EVLO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.22 M
+$8.28 M+42.47%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly earnings before interest & taxes is -$11.22 million, with the most recent change of +$8.28 million (+42.47%) on September 30, 2023.
- Over the past year, EVLO quarterly EBIT has increased by +$18.45 million (+62.19%).
- EVLO quarterly EBIT is now -115.42% below its all-time high of -$5.21 million, reached on March 31, 2017.
Performance
EVLO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$75.97 M
+$18.45 M+19.54%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM earnings before interest & taxes is -$75.97 million, with the most recent change of +$18.45 million (+19.54%) on September 30, 2023.
- Over the past year, EVLO TTM EBIT has increased by +$39.34 million (+34.12%).
- EVLO TTM EBIT is now -1358.62% below its all-time high of -$5.21 million, reached on March 31, 2017.
Performance
EVLO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EVLO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | +62.2% | +34.1% |
| 3 y3 years | -26.1% | +44.3% | +11.4% |
| 5 y5 years | -295.6% | +31.8% | +12.0% |
EVLO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.8% | at high | +62.2% | at high | +36.5% |
| 5 y | 5-year | -26.1% | +7.8% | at high | +65.5% | at high | +36.5% |
| alltime | all time | -736.3% | +7.8% | -115.4% | +65.5% | -1358.6% | +36.5% |
Evelo Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$11.22 M(-42.5%) | -$75.97 M(-19.5%) |
| Jun 2023 | - | -$19.50 M(-19.0%) | -$94.42 M(-9.5%) |
| Mar 2023 | - | -$24.09 M(+13.8%) | -$104.29 M(-4.3%) |
| Dec 2022 | -$108.92 M(-7.8%) | -$21.16 M(-28.7%) | -$108.92 M(-5.5%) |
| Sep 2022 | - | -$29.67 M(+1.0%) | -$115.31 M(-2.4%) |
| Jun 2022 | - | -$29.38 M(+2.3%) | -$118.19 M(-1.1%) |
| Mar 2022 | - | -$28.72 M(+4.3%) | -$119.55 M(+1.2%) |
| Dec 2021 | -$118.14 M(+29.6%) | -$27.55 M(-15.4%) | -$118.14 M(-0.5%) |
| Sep 2021 | - | -$32.55 M(+5.9%) | -$118.70 M(+11.7%) |
| Jun 2021 | - | -$30.73 M(+12.5%) | -$106.29 M(+11.1%) |
| Mar 2021 | - | -$27.31 M(-2.8%) | -$95.66 M(+5.0%) |
| Dec 2020 | -$91.15 M | -$28.11 M(+39.5%) | -$91.15 M(+6.3%) |
| Sep 2020 | - | -$20.14 M(+0.2%) | -$85.71 M(-1.6%) |
| Jun 2020 | - | -$20.11 M(-11.8%) | -$87.07 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$22.80 M(+0.6%) | -$88.35 M(+2.3%) |
| Dec 2019 | -$86.36 M(+48.6%) | -$22.67 M(+5.5%) | -$86.36 M(+8.4%) |
| Sep 2019 | - | -$21.50 M(+0.5%) | -$79.68 M(+6.8%) |
| Jun 2019 | - | -$21.39 M(+2.8%) | -$74.64 M(+9.0%) |
| Mar 2019 | - | -$20.80 M(+30.1%) | -$68.48 M(+17.9%) |
| Dec 2018 | -$58.10 M(+111.0%) | -$15.99 M(-2.8%) | -$58.10 M(+15.8%) |
| Sep 2018 | - | -$16.46 M(+8.1%) | -$50.18 M(+20.2%) |
| Jun 2018 | - | -$15.23 M(+46.1%) | -$41.76 M(+27.5%) |
| Mar 2018 | - | -$10.43 M(+29.2%) | -$32.75 M(+18.9%) |
| Dec 2017 | -$27.53 M(+111.4%) | -$8.07 M(+0.4%) | -$27.53 M(+41.4%) |
| Sep 2017 | - | -$8.04 M(+29.3%) | -$19.46 M(+70.3%) |
| Jun 2017 | - | -$6.22 M(+19.4%) | -$11.43 M(+119.4%) |
| Mar 2017 | - | -$5.21 M | -$5.21 M |
| Dec 2016 | -$13.03 M | - | - |
FAQ
- What is Evelo Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Evelo Biosciences?
- What is Evelo Biosciences annual EBIT year-on-year change?
- What is Evelo Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Evelo Biosciences?
- What is Evelo Biosciences quarterly EBIT year-on-year change?
- What is Evelo Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Evelo Biosciences?
- What is Evelo Biosciences TTM EBIT year-on-year change?
What is Evelo Biosciences annual earnings before interest & taxes?
The current annual EBIT of EVLO is -$108.92 M
What is the all time high annual EBIT for Evelo Biosciences?
Evelo Biosciences all-time high annual earnings before interest & taxes is -$13.03 M
What is Evelo Biosciences annual EBIT year-on-year change?
Over the past year, EVLO annual earnings before interest & taxes has changed by +$9.21 M (+7.80%)
What is Evelo Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of EVLO is -$11.22 M
What is the all time high quarterly EBIT for Evelo Biosciences?
Evelo Biosciences all-time high quarterly earnings before interest & taxes is -$5.21 M
What is Evelo Biosciences quarterly EBIT year-on-year change?
Over the past year, EVLO quarterly earnings before interest & taxes has changed by +$18.45 M (+62.19%)
What is Evelo Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of EVLO is -$75.97 M
What is the all time high TTM EBIT for Evelo Biosciences?
Evelo Biosciences all-time high TTM earnings before interest & taxes is -$5.21 M
What is Evelo Biosciences TTM EBIT year-on-year change?
Over the past year, EVLO TTM earnings before interest & taxes has changed by +$39.34 M (+34.12%)